Advancing drug development with in vivo models
In Vivo Models
Why In Vivo models matter
In vivo models are essential for preclinical drug development. Medicilon provides diverse pharmacodynamic and pharmacologic models for oncology, metabolic, neurological, cardiovascular, inflammatory, digestive, and ocular diseases.
Our comprehensive tumor and non-tumor models ensure precise efficacy evaluation, accelerating the path from discovery to clinical application.
At Medicilon, our integrated ADME/DMPK, pharmacodynamics (PD), and safety assessment studies provide high-quality, regulatory-compliant data, ensuring drug candidates advance efficiently from early research to clinical trials.
Wide Disease Coverage
Oncology, neurology, cardiovascular, metabolic, etc.
Validated & Reliable
500+ models with established methodologies
Accelerated Drug Development
Translating discovery into clinical application
Research Model Types
In Vivo animal capacity
Species
Rooms
Capacity
- NHP
2,260
- Dog
1,800
- Rabbit
570
- Rodent
24,100
- Mini-Pig
200
- Rodent (PD)
8,100
Pharmacodynamics Models
Comprehensive Pharmacodynamics models for drug evaluation
Medicilon provides GLP and non-GLP safety assessments tailored to your drug development needs. Whether for early research or regulatory submission, our precise solutions support every stage of your project.
Tumor
Neurological disease
Digestive system disease
Metabolic disease
Cardiovascular diseases
Inflammatory & immune disease
Other disease models
Pharmacologic Models
Comprehensive pharmacologic models for drug discovery
Medicilon offers a comprehensive range of tumor and non-tumor models to evaluate drug efficacy and safety. With 186+ xenograft and 100+ PDX models, plus extensive CNS, cardiovascular, and metabolic disease models, we provide precise insights to accelerate breakthrough therapies.
Tumor Models
Non-tumor Models
Ocular Disease Models
Ophthalmic disease models for specialized research
Animal models for:
Conjunctival tissue proliferation and NV
Diabetic retinopathy (DR)
Choroidal neovascularization (CNV) and subretinal fibrosis
Corneal neovascularization (Corneal NV)
Acute ocular inflammation models
Dry Eye
